A5065640604- Cancer Treatment and Pharmacology
- Breast Cancer Treatment Studies
- Advanced Breast Cancer Therapies
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
- Renal cell carcinoma treatment
- Colorectal Cancer Treatments and Studies
- Latin American socio-political dynamics
- Social Issues and Policies in Latin America
- Economic Theory and Policy
- Renal Diseases and Glomerulopathies
- Renal and related cancers
- Employment, Labor, and Gender Studies
- Business, Education, Mathematics Research
- Neuroendocrine Tumor Research Advances
- Estrogen and related hormone effects
- Business, Innovation, and Economy
Centro Oncológico de Galicia
2011-2020
GEICAM – Spanish Breast Cancer Group
2004-2020
Institute for Social Security and Services for State Workers
2019
Hospital São Lucas da PUCRS
2019
Hospital General Universitario Gregorio Marañón
2019
Centro de Investigación Biomédica en Red de Cáncer
2019
Hospital Arnau de Vilanova
2019
Hospital Universitario de Valme
2019
Hospital de Sant Pau
2019
University Hospital Complex Of Vigo
2019
SDG 8 focuses on promoting decent work and economic growth, its objective is to promote the creation of productive jobs ensure fair working conditions for all people, achieve this goal, it necessary address problem in developing countries, that people have access formal jobs. Because aforementioned implications, study aims determine whether there inequality average income by sex occupation various countries Latin America Caribbean. For resolution, a stratified descriptive analysis used and,...
620 Background: For patients (pts) with node-positive BC, TAC confers signficant disease-free and overall survival benefits vs FAC (5-fluorouracil, doxorubicin, cyclophosphamide), but a higher rate of febrile neutropenia (Martin, SABCS 2003 ab 43). In our study for node-negative we performed an interim safety analysis to assess the impact GF support on incidence TAC-related adverse events. Methods: Following surgery, operable, high-risk (St Gallen, 1998), 18–70 yr old, KPS ≥ 80%, adequate...
604 Background: Node-positive BC pts treated with TAC have a longer disease-free and overall survival but higher rate of febrile neutropenia (FN) compared FAC. We evaluated the toxicity HRQoL both regimens assessed impact adding prophylactic granulocyte GF to TAC.Methods: 1059 operable, high-risk (St Gallen, 1998), node-negative BC, 18–70 yrs old, were randomized FAC (F 500 mg/m2, A 50 C mg/m2) or (T 75 day 1 every 3wks for 6 cycles. After enrolling 224 pts, study was amended require...
Abstract Background: Triple negative breast cancers (TNBC) have a greater risk of relapse than non-TNBC. New therapeutic approaches are needed for these patients (pts). CIBOMA/2004-01_GEICAM/2003-11 is multinational, randomized phase III trial exploring adjuvant capecitabine (X) after completion standard treatment in early TNBC pts. Materials and Methods: Patients with operable, node-positive (or node-negative tumor size ≥ 1 cm), centrally confirmed hormone receptor-negative, HER2-negative...
Abstract Background: The addition of trastuzumab (T) to neoadjuvant chemotherapy increases pCR rate in patients with HER2 + breast cancer. Lapatinib (L) combination is also an active drug cancer patients. This study investigates the efficacy or lapatinib added setting. Methods: Patients (Pt) tumors greater than 2 cm (or less positive axilla) and HER2+ (Herceptest 3+ 2+ FISH+) that have not received any prior treatment for were recruited. Pts randomized receive epirubicin 90 mg/m2 plus...
La investigación tiene como objetivo estimar un modelo de importaciones sustentado en el Thyndall para su respectiva resolución. Como referencia se tomarán las investigaciones sobre tema realizados por Banco Central del Ecuador (BCE), ser focalizados los resultados la cuenta corriente, capital y reservas oficiales Ecuador. Este tipo será documental, con enfoque cuantitativo, una población datos soportadas macroeconómicos que posee BCE, lo respecta al estudio durante periodo 2020-2022. Los...
751 Background: To assess the efficacy and safety of combination NVB UFT as first or second line treatment in patients with MBC previously treated anthracyclines taxanes. Methods: Patients histologically confirmed breast cancer, measurable disease, no more one prior regimen chemotherapy for metastatic ECOG PS<2, adequate bone marrow, renal liver function were eligible. received 30 mgrs/m2 on day 1 250 daily, q2w, until progression unacceptable toxicity. Toxicity was evaluated every cycle...
Abstract Background Breast cancer is the most common malignancy in females Europe and cause of mortality women, with doxorubicin playing an important role chemotherapy (CT) regimens used this setting but limited by cardiotoxicity. Liposomal encapsulated was designed to minimize healthy tissue distribution altering pharmacokinetics thus reducing cardiotoxicity while preserving antitumor efficacy. The current study developed assess pathologic complete response (pCR), rate safety treatment...